BCL2 antagonist of cell death kinases, phosphatases, and ovarian cancer sensitivity to cisplatin

Nisha Bansal(University of Washington), Johnathan M. Lancaster(University of South Florida)
Journal of Gynecologic Oncology
January 1, 2012
Cited by 26


Related Papers